Last quarter (Q4 2022), BCAL Diagnostics Limited's total revenue was $―. In Q4, BCAL Diagnostics Limited's net income was $―. See BCAL Diagnostics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22
Total Revenue
$ ―
Cost of Revenue
$ ―
Gross Profit
$ ―
Operating Expense
$ 4.10M
Operating Income
$ -4.10M
Net Non Operating Interest Income Expense
$ 18.64K
Other Income Expense
$ 700.03K
Pretax Income
$ -3.39M
Tax Provision
$ 0.00
Earnings From Equity Interest Net Of Tax
$ ―
Net Income Common Stockholders
$ -3.39M
Basic EPS
$ -0.02
Diluted EPS
$ -0.02
Basic Average Shares
$ 204.29M
Diluted Average Shares
$ 204.29M
Dividend Per Share
$ ―
Total Operating Income As Reported
$ ―
Reported Normalized Basic E P S
$ ―
Reported Normalized Diluted E P S
$ ―
Rent Expense Supplemental
$ ―
Total Expenses
$ ―
Net Income From Continuing And Discontinued Operation
$ -3.39M
Normalized Income
$ -3.39M
Interest Expense
$ ―
EBIT
$ -4.10M
EBITDA
$ -4.08M
Currency in USD
BCAL Diagnostics Limited Earnings and Revenue History